3,4-Methylenedioxy-N-methylphentermine

From Wikipedia, the free encyclopedia
3,4-Methylenedioxy-N-methylphentermine
MDMP.svg
Names
Preferred IUPAC name
1-(2H-1,3-Benzodioxol-5-yl)-N,2-dimethylpropan-2-amine
Identifiers
CAS Number
3D model (JSmol)
ChEMBL
ChemSpider
PubChem CID
CompTox Dashboard (EPA)
InChI
  • InChI=1S/C12H17NO2/c1-12(2,13-3)7-9-4-5-10-11(6-9)15-8-14-10/h4-6,13H,7-8H2,1-3H3
    Key: CRFWCCGPRXKZSM-UHFFFAOYSA-N
  • CC(C)(NC)Cc1ccc2OCOc2c1
Properties
Chemical formula
C12H17NO2
Molar mass 207.273 g·mol−1
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
Infobox references

3,4-Methylenedioxy-N-methylphentermine (MDMP or 3,4-methylenedioxy-α,α,N-trimethylphenethylamine) is a lesser-known psychedelic drug. MDMP was first synthesized by Alexander Shulgin. In his book PiHKAL, the minimum dosage is listed as 110 mg, and the duration is listed as approximately 6 hours.[1] MDMP produces few to no effects, and is slightly similar to MDMA. Very little data exists about the pharmacological properties, metabolism, and toxicity of MDMP.

Legality[]

United Kingdom[]

This substance is a Class A drug in the Drugs controlled by the UK Misuse of Drugs Act.[2]

See also[]

  • Phenethylamine
  • Psychedelics, dissociatives and deliriants

References[]

  1. ^ MDMP entry in PiHKAL
  2. ^ "UK Misuse of Drugs act 2001 Amendment summary". Isomer Design. Retrieved 12 March 2014.


Retrieved from ""